Exosome therapy is one of the most exciting contributions of regenerative medicine to skincare and has been rapidly gaining ground in medical aesthetic practice since the mid-2020s. At Virtuana Clinic, we present the scientific foundation of this technology, its real clinical data, and its current status in Turkey with full transparency.
What Are Exosomes? A Biological Definition
Exosomes are the name given to very small membrane-enclosed vesicles secreted by all cells. Ranging in size from 30 to 150 nanometres, these structures were long regarded as "cellular waste"; however, over the past 15 years they have been understood to be critical carriers of intercellular communication.
The content of exosomes is remarkably rich:
- mRNA and miRNA: Genetic messenger molecules that regulate gene expression in target cells
- Growth factors: EGF (epidermal growth factor), VEGF, TGF-Ξ², FGF
- Proteins: Various enzymes and signalling proteins
- Lipids: Phospholipids that support membrane integrity
Thanks to this content, exosomes can transmit instructions directly to recipient cells as if they were neighbouring cells. This capacity to "update cellular epigenetics" mechanistically distinguishes them from classical growth factor concentrates such as PRP.
Mechanism of Action of Exosomes on the Skin
Exosomes applied to the skin reach dermal fibroblasts, keratinocytes, and vascular endothelial cells. Within these cells:
- Collagen Type I and III synthesis increases
- Matrix metalloproteinases (enzymes that degrade collagen) are suppressed
- Hyaluronic acid production is stimulated
- Melanin synthesis is regulated, reducing pigmentation
- Angiogenesis (new blood vessel formation) is supported, improving tissue oxygenation
- Inflammation is suppressed β particularly critical during the healing phase
The distinguishing feature of the mechanism is that, rather than merely acting as a growth factor reservoir, it reprogrammes the target cell's own production capacity. The effect is therefore more sustained compared to growth factor injection alone.
Exosome Sources: Where Are They Derived From?
Clinical exosome preparations are predominantly derived from two sources:
- Adipose-derived stem cells (ADSC): Isolated from fat tissue obtained through lipoaspiration. Autologous or allogeneic use is possible.
- Umbilical cord mesenchymal stem cells (UC-MSC): Derived from the umbilical cord after birth. Widely used in commercial products owing to large-scale production advantages and a rich exosome content.
Autologous exosome treatments (production from the patient's own cells) are both safer and more expensive, as the laboratory process is individualised. Commercial (allogeneic) preparations are standardised and more accessible; however, the donor screening process is critically important.
Exosome vs PRP Comparison
| Feature | Exosome | PRP |
|---|---|---|
| Growth factor content | Very high and standardised | Variable (differs per patient) |
| Mechanism of action | Genetic reprogramming + GF | Growth factor release |
| Shelf life | Can be stored frozen for years | Limited after preparation |
| Blood draw required | No (ready-made preparation) | Yes (blood drawn from patient) |
| Cost | Higher β contact us for pricing | More affordable |
| Level of clinical evidence | Emerging (Phase 2β3 studies) | Established (multiple RCTs) |
| FDA approval status | Under licensing process (2026) | Limited / procedure-dependent |
| Allergic reaction risk | Very low | Very low (autologous) |
Clinical Study Findings: How Effective Is It?
Acne scars: In a double-blind randomised controlled trial published in 2023 (n=48), the combination of UC-MSC-derived exosome therapy with microneedling produced a 42% greater reduction in scar volume at 12 weeks compared to microneedling alone (JAMA Dermatol, 2023).
Photoaging: A 2024 pilot study (n=30) reported a 28% improvement in skin elasticity and a 1.2-point improvement on the Fitzpatrick photoaging score following 3 sessions of exosome therapy.
Skin hydration and barrier function: Transepidermal water loss (TEWL) measurements showed a 35% reduction eight weeks after exosome treatment, indicating skin barrier repair.
When Might Exosome Therapy Be Superior to PRP?
- In treatment-resistant acne scars unresponsive to PRP
- When the patient's blood parameters are insufficient for PRP (thrombocytopenia)
- In patients who cannot attend multiple sessions (more intensive effect in a single session)
- In immunosuppressed patients (autoimmune disease or immunosuppressant use) where PRP may carry risk, exosome therapy can be safer
- In cases where a standardised, predictable outcome is desired
FDA Regulatory Status: As of 2026
The US FDA classifies exosome products as biologics, and Phase 2β3 clinical investigations are ongoing. As of 2026, cosmetic exosome preparations do not hold FDA-approved drug status. In Turkey, the Ministry of Health classifies exosome applications in the category of "biologic treatments under investigation"; therefore, they must be administered only in a clinical setting by certified physicians.
Current Situation in Turkey and Points to Note
The legal regulation of exosome therapy in Turkey has not yet been as clearly defined as for PRP. Nevertheless, clinical applications are increasing. Key points to verify for a safe treatment:
- Information on the manufacturer's certification and donor cell screening protocol for the preparation used should be requested.
- The procedure must be performed only by physicians in a clinical setting.
- No credence should be given to products sold on social media as "home exosome kits."
- Scientific evidence should be requested for any claimed effect sizes.
Exosome Skin Treatment Protocol
The standard clinical protocol is generally planned as follows:
- Number of sessions: Typically 3 sessions, 4 weeks apart
- Application method: Intradermal injection via microneedling or mesotherapy; topical application following laser in some protocols
- Social downtime: 1β3 days depending on the application method
- First results: Begin to become apparent after 4β6 weeks
- Duration of results: Generally 6β12 months; maintenance sessions may be recommended
This article is for informational purposes only. Please consult a qualified physician for treatment decisions.